Annual FCF
-$23.08 M
-$32.09 M-356.34%
31 December 2023
Summary:
TherapeuticsMD annual free cash flow is currently -$23.08 million, with the most recent change of -$32.09 million (-356.34%) on 31 December 2023. During the last 3 years, it has risen by +$137.99 million (+85.67%). TXMD annual FCF is now -356.34% below its all-time high of $9.00 million, reached on 31 December 2022.TXMD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$71.00 K
-$1.52 M-104.89%
30 September 2024
Summary:
TherapeuticsMD quarterly free cash flow is currently -$71.00 thousand, with the most recent change of -$1.52 million (-104.89%) on 30 September 2024. Over the past year, it has increased by +$5.96 million (+98.82%). TXMD quarterly FCF is now -100.24% below its all-time high of $30.16 million, reached on 31 December 2022.TXMD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$3.81 M
+$5.96 M+61.01%
30 September 2024
Summary:
TherapeuticsMD TTM free cash flow is currently -$3.81 million, with the most recent change of +$5.96 million (+61.01%) on 30 September 2024. Over the past year, it has dropped by -$15.85 million (-131.62%). TXMD TTM FCF is now -110.64% below its all-time high of $35.79 million, reached on 30 June 2023.TXMD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -356.3% | +98.8% | -131.6% |
| 3 y3 years | +85.7% | +99.8% | +97.2% |
| 5 y5 years | +82.0% | +99.7% | +97.4% |
TXMD Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -356.3% | +85.7% | -100.2% | +99.8% | -110.6% | +97.4% |
| 5 y | 5 years | -356.3% | +87.8% | -100.2% | +99.9% | -110.6% | +98.1% |
| alltime | all time | -356.3% | +87.8% | -100.2% | +99.9% | -110.6% | +98.1% |
TherapeuticsMD Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$71.00 K(-104.9%) | -$3.81 M(-61.0%) |
| June 2024 | - | $1.45 M(-734.5%) | -$9.76 M(-33.2%) |
| Mar 2024 | - | -$229.00 K(-95.4%) | -$14.61 M(-36.7%) |
| Dec 2023 | -$23.08 M(-356.3%) | -$4.96 M(-17.7%) | -$23.08 M(-291.7%) |
| Sept 2023 | - | -$6.03 M(+77.7%) | $12.04 M(-66.4%) |
| June 2023 | - | -$3.39 M(-61.0%) | $35.79 M(+94.7%) |
| Mar 2023 | - | -$8.70 M(-128.8%) | $18.39 M(+104.2%) |
| Dec 2022 | $9.00 M(-106.2%) | $30.16 M(+70.2%) | $9.00 M(-114.5%) |
| Sept 2022 | - | $17.72 M(-185.2%) | -$62.23 M(-47.4%) |
| June 2022 | - | -$20.80 M(+15.0%) | -$118.36 M(-4.7%) |
| Mar 2022 | - | -$18.08 M(-56.0%) | -$124.18 M(-14.3%) |
| Dec 2021 | -$144.92 M(-10.0%) | -$41.07 M(+6.9%) | -$144.92 M(+7.6%) |
| Sept 2021 | - | -$38.41 M(+44.3%) | -$134.69 M(+3.1%) |
| June 2021 | - | -$26.62 M(-31.4%) | -$130.60 M(-18.5%) |
| Mar 2021 | - | -$38.82 M(+25.8%) | -$160.33 M(-0.5%) |
| Dec 2020 | -$161.07 M(-15.1%) | -$30.85 M(-10.1%) | -$161.07 M(-20.2%) |
| Sept 2020 | - | -$34.31 M(-39.1%) | -$201.77 M(+3.5%) |
| June 2020 | - | -$56.35 M(+42.5%) | -$194.98 M(+2.4%) |
| Mar 2020 | - | -$39.55 M(-44.7%) | -$190.33 M(+0.4%) |
| Dec 2019 | -$189.61 M(+48.0%) | -$71.55 M(+160.0%) | -$189.61 M(+29.2%) |
| Sept 2019 | - | -$27.52 M(-46.8%) | -$146.71 M(-15.5%) |
| June 2019 | - | -$51.70 M(+33.2%) | -$173.59 M(+18.0%) |
| Mar 2019 | - | -$38.83 M(+35.5%) | -$147.14 M(+14.8%) |
| Dec 2018 | -$128.13 M(+66.4%) | -$28.65 M(-47.3%) | -$128.13 M(+6.2%) |
| Sept 2018 | - | -$54.40 M(+115.4%) | -$120.64 M(+45.4%) |
| June 2018 | - | -$25.26 M(+27.5%) | -$82.99 M(+9.0%) |
| Mar 2018 | - | -$19.82 M(-6.3%) | -$76.14 M(-1.1%) |
| Dec 2017 | -$76.98 M(+9.4%) | -$21.16 M(+26.3%) | -$76.98 M(+7.2%) |
| Sept 2017 | - | -$16.76 M(-9.0%) | -$71.84 M(-3.0%) |
| June 2017 | - | -$18.41 M(-10.9%) | -$74.07 M(+3.6%) |
| Mar 2017 | - | -$20.66 M(+29.1%) | -$71.48 M(+1.6%) |
| Dec 2016 | -$70.38 M(-11.6%) | -$16.01 M(-15.7%) | -$70.38 M(-1.5%) |
| Sept 2016 | - | -$18.99 M(+20.1%) | -$71.43 M(+0.7%) |
| June 2016 | - | -$15.81 M(-19.2%) | -$70.92 M(-11.4%) |
| Mar 2016 | - | -$19.57 M(+14.7%) | -$80.01 M(+0.5%) |
| Dec 2015 | -$79.63 M(+72.6%) | -$17.06 M(-7.7%) | -$79.63 M(+1.8%) |
| Sept 2015 | - | -$18.48 M(-25.8%) | -$78.25 M(+9.9%) |
| June 2015 | - | -$24.90 M(+29.8%) | -$71.21 M(+26.0%) |
| Mar 2015 | - | -$19.19 M(+22.4%) | -$56.50 M(+22.5%) |
| Dec 2014 | -$46.14 M(+117.1%) | -$15.68 M(+37.1%) | -$46.14 M(+30.2%) |
| Sept 2014 | - | -$11.44 M(+12.2%) | -$35.43 M(+20.3%) |
| June 2014 | - | -$10.20 M(+15.5%) | -$29.45 M(+11.3%) |
| Mar 2014 | - | -$8.83 M(+77.7%) | -$26.46 M(+24.5%) |
| Dec 2013 | -$21.25 M(+63.3%) | -$4.97 M(-9.0%) | -$21.25 M(+4.1%) |
| Sept 2013 | - | -$5.46 M(-24.2%) | -$20.40 M(+12.9%) |
| June 2013 | - | -$7.21 M(+99.5%) | -$18.06 M(+27.9%) |
| Mar 2013 | - | -$3.61 M(-12.4%) | -$14.13 M(+8.6%) |
| Dec 2012 | -$13.01 M(+160.0%) | -$4.12 M(+32.0%) | -$13.01 M(+20.7%) |
| Sept 2012 | - | -$3.12 M(-4.5%) | -$10.78 M(+17.4%) |
| June 2012 | - | -$3.27 M(+30.9%) | -$9.18 M(+36.4%) |
| Mar 2012 | - | -$2.50 M(+31.8%) | -$6.73 M(+34.5%) |
| Dec 2011 | -$5.00 M | -$1.89 M(+24.4%) | -$5.00 M(-28.7%) |
| Sept 2011 | - | -$1.52 M(+86.4%) | -$7.01 M(+61.3%) |
| June 2011 | - | -$816.80 K(+5.9%) | -$4.35 M(+25.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$771.60 K(-80.2%) | -$3.47 M(+21.9%) |
| Dec 2010 | -$2.87 M(+128.1%) | -$3.90 M(-441.7%) | -$2.84 M(-463.9%) |
| Sept 2010 | - | $1.14 M(+1671.0%) | $781.50 K(-160.3%) |
| June 2010 | - | $64.50 K(-143.7%) | -$1.30 M(-6.1%) |
| Mar 2010 | - | -$147.50 K(-46.9%) | -$1.38 M(+9.6%) |
| Dec 2009 | -$1.26 M(+846.3%) | -$277.80 K(-70.3%) | -$1.26 M(+27.1%) |
| Sept 2009 | - | -$934.50 K(+4596.0%) | -$990.30 K(+772.5%) |
| June 2009 | - | -$19.90 K(-24.9%) | -$113.50 K(-25.2%) |
| Mar 2009 | - | -$26.50 K(+181.9%) | -$151.80 K(+14.2%) |
| Dec 2008 | -$133.00 K(-138.7%) | -$9400.00(-83.7%) | -$132.90 K(-271.9%) |
| Sept 2008 | - | -$57.70 K(-0.9%) | $77.30 K(-63.7%) |
| June 2008 | - | -$58.20 K(+665.8%) | $213.10 K(-29.4%) |
| Mar 2008 | - | -$7600.00(-103.8%) | $301.80 K(-12.3%) |
| Dec 2007 | $344.10 K(+26.5%) | $200.80 K(+157.1%) | $344.10 K(+247.6%) |
| Sept 2007 | - | $78.10 K(+156.1%) | $99.00 K(-62.0%) |
| June 2007 | - | $30.50 K(-12.1%) | $260.70 K(+9.9%) |
| Mar 2007 | - | $34.70 K(-178.3%) | $237.20 K(-12.8%) |
| Dec 2006 | $272.10 K(-15.0%) | -$44.30 K(-118.5%) | $272.10 K(-24.8%) |
| Sept 2006 | - | $239.80 K(+3325.7%) | $361.90 K(+28.3%) |
| June 2006 | - | $7000.00(-89.9%) | $282.10 K(-13.9%) |
| Mar 2006 | - | $69.60 K(+53.0%) | $327.50 K(+2.3%) |
| Dec 2005 | $320.10 K(-409.9%) | $45.50 K(-71.6%) | $320.10 K(+1438.9%) |
| Sept 2005 | - | $160.00 K(+205.3%) | $20.80 K(-45.8%) |
| June 2005 | - | $52.40 K(-15.8%) | $38.40 K(+212.2%) |
| Mar 2005 | - | $62.20 K(-124.5%) | $12.30 K(-111.9%) |
| Dec 2004 | -$103.30 K(-4.1%) | -$253.80 K(-242.9%) | -$103.40 K(-189.8%) |
| Sept 2004 | - | $177.60 K(+575.3%) | $115.20 K(-222.2%) |
| June 2004 | - | $26.30 K(-149.2%) | -$94.30 K(-50.8%) |
| Mar 2004 | - | -$53.50 K(+52.0%) | -$191.80 K(+78.3%) |
| Dec 2003 | -$107.70 K(-388.0%) | -$35.20 K(+10.3%) | -$107.60 K(+144.0%) |
| Sept 2003 | - | -$31.90 K(-55.2%) | -$44.10 K(-680.3%) |
| June 2003 | - | -$71.20 K(-331.9%) | $7600.00(-85.3%) |
| Mar 2003 | - | $30.70 K(+8.5%) | $51.70 K(+37.9%) |
| Dec 2002 | $37.40 K(-73.3%) | $28.30 K(+42.9%) | $37.50 K(+941.7%) |
| Sept 2002 | - | $19.80 K(-173.1%) | $3600.00(-71.9%) |
| June 2002 | - | -$27.10 K(-264.2%) | $12.80 K(-88.3%) |
| Mar 2002 | - | $16.50 K(-394.6%) | $109.50 K(-22.0%) |
| Dec 2001 | $140.20 K(+4.6%) | -$5600.00(-119.3%) | $140.30 K(-28.9%) |
| Sept 2001 | - | $29.00 K(-58.3%) | $197.30 K(-6.0%) |
| June 2001 | - | $69.60 K(+47.1%) | $209.90 K(+32.1%) |
| Mar 2001 | - | $47.30 K(-8.0%) | $158.90 K(+18.6%) |
| Dec 2000 | $134.00 K(+176.3%) | $51.40 K(+23.6%) | $134.00 K(+3.4%) |
| Sept 2000 | - | $41.60 K(+123.7%) | $129.60 K(+77.8%) |
| June 2000 | - | $18.60 K(-17.0%) | $72.90 K(+32.1%) |
| Mar 2000 | - | $22.40 K(-52.3%) | $55.20 K(+13.8%) |
| Dec 1999 | $48.50 K(-129.1%) | $47.00 K(-411.3%) | $48.50 K(+3133.3%) |
| Sept 1999 | - | -$15.10 K(-1777.8%) | $1500.00(-91.0%) |
| June 1999 | - | $900.00(-94.3%) | $16.60 K(+5.7%) |
| Mar 1999 | - | $15.70 K | $15.70 K |
| Dec 1998 | -$166.80 K(+831.8%) | - | - |
| Dec 1997 | -$17.90 K(-141.7%) | - | - |
| Dec 1996 | $42.90 K(-18.9%) | - | - |
| Dec 1995 | $52.90 K(+2016.0%) | - | - |
| Dec 1994 | $2500.00(-108.3%) | - | - |
| Dec 1993 | -$30.20 K | - | - |
FAQ
- What is TherapeuticsMD annual free cash flow?
- What is the all time high annual FCF for TherapeuticsMD?
- What is TherapeuticsMD annual FCF year-on-year change?
- What is TherapeuticsMD quarterly free cash flow?
- What is the all time high quarterly FCF for TherapeuticsMD?
- What is TherapeuticsMD quarterly FCF year-on-year change?
- What is TherapeuticsMD TTM free cash flow?
- What is the all time high TTM FCF for TherapeuticsMD?
- What is TherapeuticsMD TTM FCF year-on-year change?
What is TherapeuticsMD annual free cash flow?
The current annual FCF of TXMD is -$23.08 M
What is the all time high annual FCF for TherapeuticsMD?
TherapeuticsMD all-time high annual free cash flow is $9.00 M
What is TherapeuticsMD annual FCF year-on-year change?
Over the past year, TXMD annual free cash flow has changed by -$32.09 M (-356.34%)
What is TherapeuticsMD quarterly free cash flow?
The current quarterly FCF of TXMD is -$71.00 K
What is the all time high quarterly FCF for TherapeuticsMD?
TherapeuticsMD all-time high quarterly free cash flow is $30.16 M
What is TherapeuticsMD quarterly FCF year-on-year change?
Over the past year, TXMD quarterly free cash flow has changed by +$5.96 M (+98.82%)
What is TherapeuticsMD TTM free cash flow?
The current TTM FCF of TXMD is -$3.81 M
What is the all time high TTM FCF for TherapeuticsMD?
TherapeuticsMD all-time high TTM free cash flow is $35.79 M
What is TherapeuticsMD TTM FCF year-on-year change?
Over the past year, TXMD TTM free cash flow has changed by -$15.85 M (-131.62%)